Title Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells
Authors Wang, Nan
Wang, Li-Wen
Gou, Bao-Di
Zhang, Tian-Lan
Wang, Kui
Affiliation Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100083, Peoples R China.
Capital Med Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100069, Peoples R China.
Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, 38 Xueyuan Rd, Beijing 100083, Peoples R China.
Keywords Realgar
Arsenic sulfide
Differentiation
MAPK pathway
HL-60
ACUTE PROMYELOCYTIC LEUKEMIA
ACTIVATED PROTEIN-KINASE
1,25-DIHYDROXYVITAMIN D-3-INDUCED DIFFERENTIATION
ARSENIC TRIOXIDE
RETINOIC ACID
SIGNALING PATHWAYS
MYELOID-LEUKEMIA
HL60 CELLS
IN-VITRO
INHIBITOR
Issue Date 2008
Publisher cell biology international
Citation CELL BIOLOGY INTERNATIONAL.2008,32,(12),1497-1505.
Abstract The clinical efficacy and safety of realgar (arsenic sulfide, As(4)S(4)) in the treatment of acute promyelocytic leukemia in China have given rise to an upsurge in research on the underlying mechanism. We prepared realgar nanoparticles (RNPs) to examine their effect on the differentiation of HL-60 cells. Treatment with RNPs at 6 mu M for 72 h induced cell differentiation that was assessed by morphological change, NBT reductive ability, and elevation of CD11b expression at both mRNA and protein levels. The RNP-induced differentiation was synergized, enhanced and suppressed by the inhibition of p38 MAPK, JNK and ERK pathways, respectively. Our findings demonstrate that MAPK signaling pathways are closely related to the RNP-induced differentiation in HL-60 cells. (c) 2008 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
URI http://hdl.handle.net/20.500.11897/156844
ISSN 1065-6995
DOI 10.1016/j.cellbi.2008.08.017
Indexed SCI(E)
PubMed
Appears in Collections: 药学院

Web of Science®


24

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.